Dose tracking
Zepbound dose tracker
Tirzepatide is the active ingredient in Zepbound. A Zepbound dose tracker gives your weekly record a clear structure: the amount prescribed, the date an injection actually happened, and the site used. PinPoint brings a dose log, scheduled reminders, titration phases, modeled levels, and vial or pen supply tracking into one place. The schedule below is a label reference for adults, not a personal prescription. Zepbound labelApp features
Sources checked

The label schedule, one phase at a time
The Zepbound label starts with 2.5 mg once weekly for four weeks, followed by 5 mg once weekly. Later increases use 2.5 mg steps after at least four weeks on the current dose. Those minimum intervals do not mean every person progresses through every strength. For weight management, the label lists 5, 10, or 15 mg as maintenance doses; for obstructive sleep apnea, it lists 10 or 15 mg. The maximum is 15 mg weekly. Zepbound label
A calendar week and a dose phase answer different questions. The calendar records when something happened; the phase records which prescribed amount applied at that time. Keeping both visible makes a period at the same strength distinguishable from an escalation. A higher row in the reference table is not a notification to change your medication.
| Weeks / phase | Label dose | Context |
|---|---|---|
| 1–4 | 2.5 mg weekly | Initiation |
| 5 onward | 5 mg weekly | After the initial four weeks |
| Later, if prescribed | 7.5, 10, 12.5, then 15 mg weekly | At least four weeks at each current dose; 2.5 mg steps |
Keep the planned week beside the actual log
PinPoint supports weekly schedules and reminders tied to your chosen day and time. Its titration phases can represent step-ups and step-downs, and past injections can be backfilled. Each injection entry can include the compound, dose, site, and pain level. That means your record can retain a late entry without turning the original reminder into evidence that the injection happened. App features
The Home curve models levels between doses using published half-life data. It can be scrubbed to a timestamp or used to preview a dose pattern. This is a mathematical display of population averages, not a measurement of medication in your blood. It does not establish whether a dose change is appropriate or whether a symptom came from a particular injection. App features
Pen versus vial: the amount and the container
The current Zepbound label includes single-dose pens, single-dose vials, multi-dose vials, and single-patient-use KwikPens. Their labeled volumes differ. PinPoint can track vials and prefilled pens side by side and estimate when supply will run out. A pen entry therefore needs its own identity rather than inheriting the concentration of an older vial entry. Zepbound labelApp features
For a hypothetical separately supplied compounded tirzepatide vial, 10 mg in a final volume of 2 mL equals 5 mg/mL. On a U-100 scale, 20 units is 0.20 mL, so the contained amount is 1 mg. This is arithmetic only, not a preparation instruction or a Zepbound dose. It does not establish that a compounded product is equivalent to the branded medicine. The tirzepatide calculator works from the concentration values entered. Arithmetic
Bring a dated record to the conversation
Side effects with severity ratings and daily notes are supported in PinPoint. A dated observation can sit alongside your injection history without the app deciding what caused it. PDF, CSV, and JSON export are available for reviewing that record. The useful output is an account of what was logged, including the timing and prescribed phase, rather than a diagnosis generated from a curve. App features
Useful distinctions
Questions
Does the table mean a dose increases every month?
No. The label sets a minimum of four weeks at the current dose before later increases. Maintenance selection depends on response and tolerability, so the table does not assign an automatic escalation date. Zepbound label
Can PinPoint track both a pen and a vial?
Yes. The app description lists side-by-side tracking for vials and prefilled pens, with a supply forecast. The medication presentation and concentration still need to match the actual product record. App features
Your record, together
Keep the details attached to the date.
Dose history, reminders, daily notes, and the context you choose to record. PinPoint app features.
Get PinPoint on the App StoreSources & scope
Label facts link to the full prescribing information. Product claims use the supplied PinPoint app description. Numerical examples show their assumptions and arithmetic.
- PinPoint feature description
Only feature claims verified against the supplied description. No prices, clinical recommendations or inferred tablet inventory.
- Arithmetic shown on this page
Numerical derivations, dimensional distinctions and declared assumptions only.
Concentration mg/mL = total mg / final mL. U-100 volume mL = units / 100. Contained mg = concentration * volume. These are hypothetical examples, not preparation instructions or clinical amounts.
- How to read this reference
Editorial organization, explicit scope limits, and interpretation of the cited label or app evidence. No additional medical facts.
- Zepbound prescribing information
2 (schedule/administration), 3 (presentations), 6.1–6.2 (adverse reactions), 14 (study identity), Medication Guide and Instructions for Use. DailyMed set ID:
487cd7e7-434c-4925-99fa-aa80b1cc776b.